Privia Health Group, Inc. (PRVA) shares surged 6.45% in pre-market trading on Thursday following the release of its impressive first-quarter 2025 financial results, an upbeat full-year outlook, and the announcement of market expansion. The healthcare company's performance significantly exceeded analyst expectations, demonstrating strong growth and operational execution.
For Q1 2025, Privia Health reported adjusted earnings per share of $0.22, dramatically outperforming the analyst consensus estimate of $0.05 and marking a 22.22% increase from the same period last year. The company's adjusted EBITDA reached $26.9 million, surpassing the estimated $23.4 million. While quarterly revenue of $480.1 million missed analyst estimates, it still represented a solid 15.62% year-over-year growth.
Adding to the positive sentiment, Privia Health raised its full-year 2025 outlook to the mid- to high-end of its guidance ranges for all metrics. The company also announced its expansion into the Arizona market through a partnership with Integrated Medical Services, further extending its presence to 15 states and the District of Columbia. This strategic move, coupled with the strong financial performance and optimistic forecast, has bolstered investor confidence in Privia Health's growth prospects, driving the significant pre-market rally.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.